<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:819347994;
mso-list-template-ids:729588568;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1
{mso-list-id:1017006914;
mso-list-template-ids:-1434188964;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2
{mso-list-id:1024094285;
mso-list-template-ids:241850308;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3
{mso-list-id:1966807366;
mso-list-template-ids:2109100728;}
@list l3:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<div>
<div>
<div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"><img width="542" height="113" id="_x0000_i1025" src="cid:image001.jpg@01D8060D.5C6A1FF0" alt="image.png"><o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"><o:p> </o:p></span></p>
</div>
<div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Dear Colleagues:</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"><br>
We are very pleased to announce that <b>TRANSCEND</b> - our Stem Cell Training Program – successfully recruited its first cohort, which began January 1, 2022. </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">The purpose of this letter is to announce the recruitment of our second cohort that will enter the Program either Spring quarter 2022 or July 1, 2022. Both predoctoral
and postdoctoral applications will be accepted. <u>Applications for the second cohort must be received by February 25<sup>th</sup> by 5 PM</u>.</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Criteria that will be evaluated include</span></u></b><b><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">: </span></b><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Relevance
to human stem cell research, qualification of candidate, training environment, qualifications of mentor, and scientific merit of research plan. Nominees for pre-doctoral fellowships must be enrolled in a Ph.D. graduate program at UCR. </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">TRANSCEND will provide the following:</span></u></b><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Ph.D.:</span></u></b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> CIRM training grant annual stipend</span></u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">:
$36,000</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Tuition and Fees</span></u></b><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">: up to $12,034.</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Postdoctoral Trainees</span></u></b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">: CIRM training grant annual stipend:</span></u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> $51,000</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Ph.D. and Postdoctoral Trainee research and travel allowance</span></u></b><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">: $5,900/year
(laboratory supplies, travel, books etc.).</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Note: Supplementation to stipends and fees should come from unrestricted funds.</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Please note the following</span></u></b><b><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">:</span></b><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="color:black;mso-list:l2 level1 lfo1"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">TRANSCEND aims to recruit trainees from scientifically diverse backgrounds.</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></li></ul>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="color:black;mso-list:l1 level1 lfo2"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">We are encouraged by the funding agency to recruit and retain trainees from many different backgrounds, including underrepresented
minorities and trainees with special needs or disabilities.</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></li></ul>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="color:black;mso-list:l0 level1 lfo3"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">The Mentor is expected to have an active, securely funded research program in an area related to basic or translational stem-cell
research.</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></li><li class="MsoNormal" style="color:black;mso-list:l0 level1 lfo3"><span style="font-size:7.0pt;color:#222222"> </span><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#222222">Predoctoral appointments are for a 3-year period, and Postdoctoral
appointments are for a 2-year period, with yearly continuation subject to successful evaluation of progress by the training program.</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></li></ul>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="color:black;mso-list:l3 level1 lfo4"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">The trainees and mentors will have to adhere fully to the scientific and fiscal guidelines of CIRM. </span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><b><u><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Application Packets for each candidate should include</span></u></b><b><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">:</span></b><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:.5in">
<span style="font-size:10.0pt;font-family:"Arial",sans-serif">1.</span><span style="font-size:7.0pt"> </span><span style="font-size:10.0pt;font-family:"Arial",sans-serif">Cover page attached to this letter (which has been updated since previous call for
applications) plus each of the following:</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></p>
<p style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:.5in">
<span style="font-size:10.0pt;font-family:"Arial",sans-serif">2.</span><span style="font-size:7.0pt"> </span><span style="font-size:10.0pt;font-family:"Arial",sans-serif">Current Biosketch (for both the candidate and mentor – please use NIH form)</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></p>
<p style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:.5in">
<span style="font-size:10.0pt;font-family:"Arial",sans-serif">3.</span><span style="font-size:7.0pt"> </span><span style="font-size:10.0pt;font-family:"Arial",sans-serif">Candidate’s research plan (1 page max) and statement of career plan (1/2 page max).</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></p>
<p style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:.5in">
<span style="font-size:10.0pt;font-family:"Arial",sans-serif">4.</span><span style="font-size:7.0pt"> </span><span style="font-size:10.0pt;font-family:"Arial",sans-serif">Statement of the mentor’s current and pending research funding (include as part of
the Biosketch).</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></p>
<p style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:.5in">
<span style="font-size:10.0pt;font-family:"Arial",sans-serif">5.</span><span style="font-size:7.0pt"> </span><span style="font-size:10.0pt;font-family:"Arial",sans-serif">A letter of nomination from the mentor, evaluating the candidate’s experience and
qualifications, explaining the nature of the research and training experience proposed for the candidate.</span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></p>
<p style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:.5in">
<span style="font-size:10.0pt;font-family:"Arial",sans-serif">6.</span><span style="font-size:7.0pt"> </span><span style="font-size:10.0pt;font-family:"Arial",sans-serif">A statement that the candidate is committed to take the three formal courses when
they are next offered and the two-yearly stem cell seminars (CMDB 255 and 256) every time they are offered. The three formal courses are: CMDB 207 Stem Cell Biology and Medicine; Ethical, Legal and Social Implications of Stem Cell Research; and Science-to-Policy
(S2P) Certification Course for stem cell researchers. </span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></p>
<p style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt">
<span style="font-size:10.0pt;font-family:"Arial",sans-serif">7.</span><span style="font-size:7.0pt"> </span><span style="font-size:10.0pt;font-family:"Arial",sans-serif">A statement that the mentor is willing to participate actively in the Stem Cell Training
Program and ensure the candidate will pursue the proposed stem cell project while participating in TRANSCEND. This can be incorporated in the mentor’s nomination letter (please bold this section). </span><span style="font-family:"Calibri",sans-serif"><o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">8. The above documents should be combined into a single PDF file, which should be submitted by the candidate’s mentor to Rachel Behar (</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><a href="mailto:rbeha001@ucr.edu" target="_blank"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#954F72">rbeha001@ucr.edu</span></a></span><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">). </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> <br>
Underrepresented minorities are encouraged to apply.</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Applications can be submitted at any time. To be considered for the second cohort, your complete application packet should be received <b>by 5PM</b> <b>February 25<sup>th</sup>,
2022</b>. </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">You can distribute this letter to others.</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Sincerely,</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Prue Talbot, Ph.D. </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Director</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Huinan Liu, Ph.D.</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Associate Director</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Martin Garcia-Castro, Ph.D.</span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Associate Director </span><span style="font-size:13.5pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<p class="MsoNormal">-- <o:p></o:p></p>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<p class="MsoNormal"><span style="color:#666666">Rachel Z. Behar, Ph.D.</span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="color:#666666">Academic Coordinator, UCR Stem Cell Core</span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="color:#666666">University of California, Riverside</span><o:p></o:p></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>